NSF AIRFoundry to advance RNA technology and nanoparticle design

In a typical foundry, raw materials like steel and copper are melted down and poured into molds to assume new shapes and functions.

A rational design approach to RNA targeting could replace large-scale screening – Pharmaceutical Technology

Maria Duca speaking at the ELRIG Drug Discovery conference in London, UK. Credit: Frankie Fattorini/ GlobalData As interest mounts in using RNA as a therapeutic

October 5, 2024

Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors | Psychedelic Invest

Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) (“Lobe” or the “Company”), a biopharmaceutical company focused on developing transformative medicines to treat rare diseases today announced

May 31, 2024

BMS expands Krazati’s FDA label to include colorectal cancer

BMS added Krazati to its portfolio when it acquired Mirati Therapeutics for $5.8bn. Credit: Katherine Welles/Shutterstock. The US Food and Drug Administration (FDA) has approved

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.